Itraconazole, an antifungal medication, has been proposed as a possible therapeutic for COVID-19.
In vitro activity
In an October, 2020 preprint, itraconazole showed anti-SARS-CoV-2 activity in Vero and Calu-3 cells.
Contributed by 
Except where otherwise noted, text content is licensed under a Creative Commons Attribution-ShareAlike License. See copyright information.